Judith Balmaña Gelpi

Title: Judith Balmaña Gelpi: Innovator in Cancer Treatment Methods

Introduction

Judith Balmaña Gelpi is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of oncology through her innovative methods for determining cancer treatment sensitivity. Her work is particularly relevant in the context of personalized medicine, where understanding a patient's response to treatment can greatly influence therapeutic outcomes.

Latest Patents

Judith holds a patent for her invention titled "Methods based on the detection of RAD51 foci in tumor cells." This method allows for the determination of whether a subject diagnosed with cancer is sensitive or resistant to anti-cancer treatments. The invention is based on analyzing the level of cells with RAD51 foci in tumor cell samples, specifically when the subject has not received certain chemotherapy treatments within 24 hours prior to sample isolation. This innovative approach has the potential to enhance treatment strategies for cancer patients.

Career Highlights

Throughout her career, Judith has worked with notable organizations, including the Fundació Privada Institut d'Investigació Oncològica de Vall Hebron and AstraZeneca U.K. Limited. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer treatment.

Collaborations

Judith has collaborated with esteemed colleagues such as Violeta Serra Elizalde and Cristina Cruz Zambrano. These partnerships have further enriched her research and development efforts in oncology.

Conclusion

Judith Balmaña Gelpi's innovative work in cancer treatment methods exemplifies the importance of research and development in improving patient outcomes. Her contributions to the field are invaluable and highlight the potential of personalized medicine in oncology.